Clinical trial
Active Surveillance Plus (AS+): Local Tumor Control With High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer
NCT04549688 is registered in ClinicalTrials.gov with The Hospital of Vestfold as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Active Surveillance Plus (AS+): Local Tumor Control With High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer
- Lead sponsor
- The Hospital of Vestfold
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 1, 2020
- Completion date
- September 30, 2030
- Enrollment
- 250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer